SMMT PEER ANALYSIS

Summit Therapeutics PLC — metric-by-metric comparison with peers and the industry median

SMMTSummit Therapeutics PLC

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

SMMTIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	SMMT	CSL	TLX	MSB	Ind. Median
P/E	—	30.02	—	—	17.81
P/B	22.37	2.24●	6.56	—	3.49
EV/EBITDA	—	10.37●	123.31	—	14.92
P/S	—	2.67●	3.34	31.91	10.89

Financial Health
Metric	SMMT	CSL	TLX	MSB	Ind. Median
Current Ratio	7.41●	2.57	1.43	—	5.90
Debt/Equity	3.7%●	67.4%	112.3%	—	10.9%
NetDebt/EBITDA	0.69●	2.22	13.13	—	1.15

Profitability
Metric	SMMT	CSL	TLX	MSB	Ind. Median
Net Margin	—	9.2%●	-0.9%	-115.3%	-125.7%
ROE	-256.3%	7.7%●	-1.8%	-11.3%	-47.5%
ROA	-221.2%	3.8%●	-0.7%	-8.6%	-35.8%
EBITDA Margin	—	32.8%●	3.0%	-76.6%	-105.8%

Growth + Dividend
Metric	SMMT	CSL	TLX	MSB	Ind. Median
Rev. Growth	—	4.8%	56.3%	410.4%●	5.1%
NI Growth	—	-39.4%	—	—	12.1%
Div. Yield	—	2.5%●	—	0.0%	0.2%
Payout	—	103.1%	—	0.0%	0.0%

Valuation
Metric	SMMT	APGE	PTGX	CORT	TGTX	IBRX	Ind. Median
P/E	—	—	—	199.72	19.22●	—	17.81
P/B	22.37	7.41	14.14	15.00	15.23	-10.52●	3.49
EV/EBITDA	—	—	—	652.64	60.71●	—	14.92
P/S	—	—	125.16	12.44●	12.68	64.90	10.89

Financial Health
Metric	SMMT	APGE	PTGX	CORT	TGTX	IBRX	Ind. Median
Current Ratio	7.41	32.59●	17.76	2.86	5.81	6.67	5.90
Debt/Equity	3.7%	0.6%	1.5%	1.5%	129.2%	-129.3%●	10.9%
NetDebt/EBITDA	0.69	3.86	4.72	-23.21●	1.59	-1.02	1.15

Profitability
Metric	SMMT	APGE	PTGX	CORT	TGTX	IBRX	Ind. Median
Net Margin	—	—	-154.9%	6.2%	66.0%●	-606.2%	-125.7%
ROE	-256.3%	-28.5%	-17.1%	7.3%	112.6%●	—	-47.5%
ROA	-221.2%	-27.4%	-15.9%	5.8%	42.3%●	-179.8%	-35.8%
EBITDA Margin	—	—	-153.8%	1.8%	21.4%●	-515.2%	-105.8%

Growth + Dividend
Metric	SMMT	APGE	PTGX	CORT	TGTX	IBRX	Ind. Median
Rev. Growth	—	-100.0%	-64.4%	12.2%	81.3%	351.5%●	5.1%
NI Growth	—	—	—	-64.0%	1,079.8%●	—	12.1%
Div. Yield	—	—	—	—	0.0%	—	0.2%
Payout	—	—	—	—	0.0%	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on SMMT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.